Impact of Viral Infections on Hematopoiesis
This special issue belongs to
|Research & Reviews: Journal of Oncology and Hematology
Deadline for Manuscript Submission
|March 31st, 2023
Deadline for Publication
|April 15, 2023
Special Issue Description
Hematopoiesis is a functioning, persistent cycle including the creation and utilization of mature platelets that comprise the haemato-lymphoid system. All platelets emerge from a little populace of hematopoietic undifferentiated organisms (HSCs) in the bone marrow (BM) that have two remarkable properties: self-recharging limit, the capacity to create themselves, and multi-genealogy separation limit, the capacity to deliver all platelet types. HSCs just incidentally led to new progenitors and are rather secured and supported by an intricate microenvironment of occupant hematopoietic and non-hematopoietic cells. This BM specialty produces factors that keep up with the peacefulness, self-restoration, and endurance of the HSCs.
In any case, upon stress actuated by cytotoxic harm, transplantation, aggravation, or contamination, the pool of quiet HSCs is enacted and expected to add to the hematopoietic cycle effectively. Viral contaminations can make direct and indirect harm HSPCs and the encompassing tissue. Direct pathogenic impacts rely upon viral tropism and viral cycle, and there are a couple of instances of direct contamination of HSPCs that lead to modified BM yield, e.g., parvovirus B19. In any case, the perplexing collaborations between infections, HSPCs, and the BM microenvironment are overlooked right now. One such case is CMV, which can contaminate both stroma and HSPC, with the final product of ongoing dormant disease and no clear BM pathology. Intense viral contaminations ordinarily cause transient aplasia, somewhat connected with the impact of type I IFNs, and to direct viral disease, in which both HSPCs and stromal cells are drained. Infection-explicit T cells produce extensive measures of IFNγ and TNFα that thusly influence hematopoiesis; also, persistent (idle or dynamic) viral diseases can initiate constant aggravation, related to an expanded chance of creating BM pathology.
Recognition of viral PAMPs by PRRs prompts the creation of type I IFNs, with antiviral and safe stimulatory properties that are advantageous for viral freedom. Momentary impacts of type I IFNs on hematopoiesis highlight brief aplasia and potential slanting to megakaryopoiesis, yet the drawn-out impacts of type I IFN motioning on hematopoiesis are still under banter and might be less pernicious than those depicted for IFNγ, because of the presence of administrative systems.
* Bone Marrow
* Hematopoietic Undifferentiated Organisms
* Viral Contaminations
Manuscript Submission information
Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.